L. Hansen Carl - May 31, 2024 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
May 31, 2024
Transactions value $
$151,538
Form type
4
Date filed
6/3/2024, 04:21 PM
Previous filing
Feb 27, 2024
Next filing
Sep 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Options Exercise $152K +56.1K +7.69% $2.70 786K May 31, 2024 Direct
holding ABCL Common Shares 55.8M May 31, 2024 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share option (right to buy) Options Exercise $0 -56.1K -0.67% $0.00 8.37M May 31, 2024 Common Shares 56.1K $2.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person.
F2 The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.